athenahealth, Inc. | August 03, 2022
athenahealth, a leading provider of network-enabled software and services for medical groups and healthcare organizations nationwide, and health technology pioneer, DrFirst, today announced they are partnering to help improve medication adherence and patient outcomes. athenahealth’s large user base will now be able to send patient medication notifications powered by DrFirst’s RxInform to reduce prescription abandonment and help patients adhere to their recommended medication therapies.
Patients abandon 20% to 30% of new prescriptions, whether due to high out-of-pocket costs, concerns about side effects, procrastination, or other factors. This lack of medication adherence can lead to increased total cost of patient care and undesirable health outcomes, such as disease progression, hospitalization, or even death.
Now, the athenahealth electronic health record system that helps providers maximize clinical productivity and focus on delivering high-quality care to patients connects with RxInform, which automatically triggers a secure message to a patient’s mobile device when a clinician sends a prescription order to a pharmacy. From the message, patients may receive cost savings opportunities as available for a prescribed therapy and can view detailed information regarding their prescriptions, with a focus on behavioral and educational issues that have been proven to reduce prescription abandonment. The experience is seamless for the prescriber and helps them ensure the best outcomes for their patients.
“We are always looking for innovative ways to drive better results for our customers and their patients – especially as the industry shifts more toward value-based care. Every provider wants to minimize prescription abandonment rates because non-adherence to medication regimens negatively affects desired clinical outcomes. By adding RxInform to the latest release of athenaOne, we are immediately giving all our providers an automated function within their established prescribing workflows to support better patient outcomes.”
Paul Brient, chief product officer for athenahealth
Since 2017, RxInform has received more than three million patient ratings, with 92% overall positive scores. These results indicate that patients welcome these messages, presenting new opportunities for providers to nurture patient relationships and build loyalty outside of the exam room.
“Primary care providers and specialists who care for high-risk patients need tools to help people take their medications as prescribed,” said G. Cameron Deemer, president of DrFirst. “We’re pleased to partner with athenahealth to give its network of approximately 145,000 providers access to the RxInform platform so they can help patients overcome the common hurdles that lead them to abandon their medications at the pharmacy.”
About athenahealth, Inc.
athenahealth creates innovative healthcare technology that connects clinicians, patients, payers, and partners in differentiated ways. Our electronic health records, revenue cycle management, and patient engagement tools allow anytime, anywhere access, driving better financial outcomes for our customers and enabling our provider customers to deliver better quality care. In everything we do, we’re inspired by our vision to create a thriving ecosystem that delivers accessible, high-quality, and sustainable healthcare for all.
Since 2000, DrFirst has pioneered healthcare technology solutions and consulting services that securely connect people at touchpoints of care to improve patient outcomes. We create unconventional solutions that solve care collaboration, medication management, price transparency, and adherence challenges faced in healthcare. We unite the Healthiverse—the interconnected healthcare universe—by providing our clients with real-time access to the information they need, exactly when and how they need it, so patients get the best care possible. DrFirst solutions are used by nearly 325,000 healthcare professionals, including 220,000 prescribers, 70,000 pharmacies, 290 HIS/EHRs, and 1,500 hospitals in the U.S. and Canada.
HCA Healthcare, Inc. | October 07, 2022
HCA Healthcare, Inc. one of the nation’s leading healthcare providers, announced that it will give $1.5 million to Tennessee State University to create scholarship opportunities for students enrolled in the Dr. Levi Watkins, Jr. Institute and the Department of Computer Science within the College of Engineering. This gift is part of the organization’s larger commitment to give $10 million over three years to Historically Black Colleges and Universities (HBCUs) and Hispanic Serving Institutions. Since making the pledge in 2021, HCA Healthcare has announced approximately $5.25 million in donations towards multiple partnerships.
“We are proud of the long-standing relationship we have fostered with TSU. By strengthening our partnership, we will be able to create additional opportunities for TSU students and further our commitment to advancing diversity in healthcare.”
Sam Hazen, chief executive officer for HCA Healthcare
Funds from this gift will support scholarships for students participating in the university’s Dr. Levi Watkins, Jr. Institute Accelerated Medical Pathway program. Three two-year scholarships for rising juniors and three two-year scholarships for graduate students within the College of Engineering will also be awarded. Through these scholarship programs, HCA Healthcare Scholars and HCA Healthcare ITG Scholars will be provided with hands on shadowing opportunities, mentors, seminars, leadership sessions, guest speakers and career guidance. HCA Healthcare will also offer dedicated internship opportunities in the ITG Pathways, Technical Resident and Part-Time Internship programs annually to TSU students.
“It is an honor to partner with TSU to support more students pursuing careers in healthcare and, in turn, helping to build a diverse talent pipeline of healthcare professionals,” said Sherri Neal, chief diversity officer of HCA Healthcare. “Increasing the diversity of our healthcare workforce is vital to providing equitable, culturally competent care to our communities.”
HCA Healthcare has a history of partnering with TSU. In 2015, HCA Healthcare gave $1 million to TSU to fund internship opportunities and support the growth of the Health Information Management program. Marty Paslick, chief information officer for HCA Healthcare, serves as an advisory board member for the College of Engineering where there are currently seven HCA Healthcare colleagues serving as adjunct faculty.
“We applaud and thank HCA Healthcare for this generous gift and continued support of TSU, and our talented students,” said Glenda Glover, president of Tennessee State University. “This investment in our students helps them to become the future doctors and health technology leaders they aspire to be. HCA Healthcare is making their dreams a reality.”
HCA Healthcare is committed to partnering with organizations to help develop a diverse pool of future healthcare leaders. Included among these partnerships is $750,000 to The University of Texas at El Paso to create multiple graduate-degree opportunities for students interested in healthcare careers. The company also gifted $1.5 million to Florida International University’s (FIU) Nicole Wertheim College of Nursing & Health Sciences (NWCNHS) to expand its faculty, offer scholarships to increase enrollment and help address the national nursing shortage. In 2021, HCA Healthcare announced a $1.5 million investment in Florida A&M University’s (FAMU) School of Allied Health Sciences to strengthen students’ pathways from undergraduate to graduate to management careers in the healthcare industry. In 2019, the HCA Healthcare Scholars at Fisk University program was created to provide scholarships, career planning support and internship opportunities for high-achieving undergraduates. These partnerships and others with industry- and school-based associations are part of HCA Healthcare’s continued efforts to strengthen the diversity of the organization’s talent pipeline.
About HCA Healthcare
Nashville-based HCA Healthcare is one of the nation’s leading providers of healthcare services comprising 182 hospitals and approximately 2,300 ambulatory sites of care, including surgery centers, freestanding ERs, urgent care centers, and physician clinics, in 20 states and the United Kingdom. With its founding in 1968, HCA Healthcare created a new model for hospital care in the United States, using combined resources to strengthen hospitals, deliver patient-focused care and improve the practice of medicine. HCA Healthcare has conducted a number of clinical studies, including one that demonstrated that full-term delivery is healthier than early elective delivery of babies and another that identified a clinical protocol that can reduce bloodstream infections in ICU patients by 44%. HCA Healthcare is a learning health system that uses its more than 35 million annual patient encounters to advance science, improve patient care and save lives.
About Tennessee State University
Founded in 1912, Tennessee State University is Nashville’s only public university, and is a premier, historically black university and land-grant institution offering 39 bachelor’s degree programs, 25 master’s degree programs, one education specialist degree, and eight doctoral degrees. TSU is a comprehensive research intensive institution with a R-2 Carnegie designation, and has a graduate school on its downtown Avon Williams Campus, along with the Otis Floyd Nursery Research Center in McMinnville, Tennessee. With a commitment to excellence, Tennessee State University provides students with a quality education in a nurturing and innovative environment that prepares them as alumni to be global leaders in every facet of society.
KORU Medical | October 05, 2022
KORU Medical Systems, Inc. a leading medical technology company focused on the development of innovative and easy-to-use home infusion solutions, announced its membership in the Subcutaneous (SC) Drug Development & Delivery Consortium making it one of the first device companies to be added to the Consortium.
“The Consortium creates an important forum to identify and address key challenges and opportunities across the SC field. Key industry experts can collaborate on issues at the clinical, regulatory, and commercial level and work towards advancing the SC market and creating the best outcomes for patients. I am excited for KORU Medical’s membership as one of the first device companies and look forward to advancing SC drug delivery.”
Linda Tharby, KORU Medical’s President and CEO
The Consortium was convened in 2018 as a community of well-recognized industry experts with decades of experience in the pharmaceutical drug delivery, device development, and commercialization space. The Consortium was built upon a strong desire for clear and transparent evidence-based communication of existing SC technologies and information. The Consortium’s mission is to identify current and future unmet medical needs within a dynamic SC drug delivery and development environment to transform patient care and improve patient outcomes. As a member, KORU Medical will contribute to advancing understanding of patient preference for SC therapy and the clinical trial strategy and technology for high-volume SC drugs. KORU Medical was one of the first companies to develop technology for SC biologics with volumes above 5mL, and its Freedom System is used by over 25,000 patients today to receive SC therapy. KORU Medical is established as the market leader in above 10mL and will bring this deep expertise in patient experience and subcutaneous injection technology to the Consortium.
About KORU Medical
KORU Medical develops, manufactures, and commercializes innovative and easy-to-use specialty infusion solutions that improve quality of life for patients around the world. The FREEDOM Syringe Infusion System (the “Freedom System”) currently includes the FREEDOM60® and FreedomEdge® Syringe Infusion Drivers, Precision Flow Rate Tubing™ and HIgH-Flo Subcutaneous Safety Needle Sets™. These devices are used for infusions administered in the home and alternate care settings.